Long-Term Efficacy and Complete Scalp Hair Regrowth in Patients With Alopecia Areata Receiving Ritlecitinib 50 mg QD Up to 3 Years in the ALLEGRO Clinical Trial Program

    Brett King, Rodney Sinclair, Lidia Rudnicka, Sergio Vañó‐Galván, Bianca Maria Piraccini, Manabu Ohyama, Wenyu Wu, Robert Wołk, Stephen Goodrich, Dalia Wajsbrot, Helen Tran, Alexandre Lejeune

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results